                         SEQUENCE LISTING

<110>  Trustees of the University of Pennsylvania
       University of Thrace
       Lambris, John D.
       Ritis, Konstantinos
 

<120>  METHOD OF INHIBITING BIOMATERIAL-INDUCED PROCOAGULANT ACTIVITY USING COMPLEMENT INHIBITORS


<130>  34092-047 (V4944 WO)

<140>  Not yet assigned
<141>  2009-09-29


<150>  US 61/101,453
<151>  2008-09-30

<160>  5    

<170>  PatentIn version 3.4


<210>  1
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<220>
<221>  DISULFID
<222>  (2)..(12)

<400>  1

Ile Cys Val Val Gln Asp Trp Gly His His Arg Cys Thr 
1               5                   10 


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is Gly or is missing

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa is Ile, Val, Leu, Ac-Ile, Ac-Val or Ac-Leu

<220>
<221>  DISULFID
<222>  (3)..(13)

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  Xaa is Trp or an analog of Trp

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  Xaa is His, Ala, Phe or Trp

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Xaa is L-Thr, D-Thr, Ile, Val or Gly

<220>
<221>  VARIANT
<222>  (15)..(15)
<223>  Xaa is Asn or Ala, or is missing

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  Xaa is Asn, or is missing

<400>  2

Xaa Xaa Cys Val Xaa Gln Asp Trp Gly Xaa His Arg Cys Xaa Xaa Xaa
1               5                   10                  15


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is Gly or is missing

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  Xaa is Ile, Val, Leu, Ac-Ile, Ac-Val or Ac-Leu

<220>
<221>  DISULFID
<222>  (3)..(13)

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  Xaa is Trp or an analog of Trp

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  Xaa is Trp or an analog of Trp

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  Xaa is His, Ala, Phe or Trp

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Xaa is L-Thr, D-Thr, Ile, Val or Gly
<220>
<221>  VARIANT
<222>  (15)..(15)
<223>  Xaa is Asn or Ala, or is missing

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  Xaa is Asn, or is missing

<400>  3

Xaa Xaa Cys Val Xaa Gln Asp Xaa Gly Xaa His Arg Cys Xaa Xaa Xaa 
1               5                   10                  15


<210>  4
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  DISULFID
<222>  (2)..(12)

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  1-methyl Tryptophan

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  4

Ile Cys Val Trp Gln Asp Trp Gly Ala His Arg Cys Thr 
1               5                   10              


<210>  5
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  DISULFID
<222>  (2)..(12)

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  N-methyl Glycine

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  1-methyl Tryptophan

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  5

Ile Cys Gly Trp Gln Asp Trp Gly Ala His Arg Cys Thr 
1               5                   10              
